Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 5

1.

Early intensive vs a delayed conservative simvastatin strategy in patients with acute coronary syndromes: phase Z of the A to Z trial.

de Lemos JA, Blazing MA, Wiviott SD, Lewis EF, Fox KA, White HD, Rouleau JL, Pedersen TR, Gardner LH, Mukherjee R, Ramsey KE, Palmisano J, Bilheimer DW, Pfeffer MA, Califf RM, Braunwald E; Investigators.

JAMA. 2004 Sep 15;292(11):1307-16. Epub 2004 Aug 30.

PMID:
15337732
2.

Statins for acute coronary syndrome.

Vale N, Nordmann AJ, Schwartz GG, de Lemos J, Colivicchi F, den Hartog F, Ostadal P, Macin SM, Liem AH, Mills E, Bhatnagar N, Bucher HC, Briel M.

Cochrane Database Syst Rev. 2011 Jun 15;(6):CD006870. doi: 10.1002/14651858.CD006870.pub2. Review. Update in: Cochrane Database Syst Rev. 2014;9:CD006870.

PMID:
21678362
3.

Statins for acute coronary syndrome.

Vale N, Nordmann AJ, Schwartz GG, de Lemos J, Colivicchi F, den Hartog F, Ostadal P, Macin SM, Liem AH, Mills EJ, Bhatnagar N, Bucher HC, Briel M.

Cochrane Database Syst Rev. 2014 Sep 1;(9):CD006870. doi: 10.1002/14651858.CD006870.pub3. Review.

PMID:
25178118
4.

Effects of aggressive statin therapy on patients with coronary saphenous vein bypass grafts: a systematic review and meta-analysis of randomized, controlled trials.

Kang S, Liu Y, Liu XB.

Clin Ther. 2013 Aug;35(8):1125-36. doi: 10.1016/j.clinthera.2013.06.006. Epub 2013 Aug 7. Review.

PMID:
23932462
5.

Are intensive lipid-lowering regimens an optimal economic strategy in patients with ACS? An acute and chronic perspective.

Ara R, Rafia R, Ward SE, Wierzbicki AS, Reynolds TM, Rees A, Pandor A.

Expert Rev Pharmacoecon Outcomes Res. 2009 Oct;9(5):423-33. doi: 10.1586/erp.09.42. Review.

PMID:
19817526

Supplemental Content

Support Center